Monday, October 16, 2017

Healthy Markets - Healthy Earnings?

Monday, October 16, 2017 – U.S. stock markets seemed hesitant this past week but continued into record territory. The Dow Jones Industrial Average and S&P 500 Index saw small gains of less than a percent but still in the green for the fifth consecutive week. The small-cap Russell 2000 Index lagged and recorded a humble loss for the week. Consumer Staples performed well, boosted with help from a surge in Walmart following their announcement of a massive repurchase program and a strong rise in online sales as the holidays draw near.

As of late, stock valuations have seen record setting highs and are forecasted to continue to grow with earnings on the rise. This week brought the first releases of major 3Q earnings reports. Major banks like JP Morgan Chase and Citigroup declined Thursday after reporting lower trading revenues and frequent credit card losses. Wells Fargo reported an earnings decline on Friday, further impacting the broader financials sector. Broadly, we have seen investors side with Industrials, Tech and other resilient sectors in response to this strain on Financials. This can be observed first hand on the ETF Global Scanner.

Even with the turbulent political environment, a series of positive economic reports may have helped compensate for the disruption in Washington. Initial jobless claims during the previous week rebounded, as the impact of hurricanes Harvey, Irma, and Maria on the labor market appeared to be dissipating. Retail sales also jumped in September, clearly showing further resilience in the face of the natural disasters. In fact, consumers entered October feeling better about the economy than they had in over a hundred years, according to the University of Michigan’s gauge of consumer sentiment, which was released Friday.

In ETFs, some of the biggest news included President Trump’s first key piece of legislation in regards to ETF research. Current securities laws offer legal protections for broker-dealers that issue public research reports on some asset classes. Research reports on exchange traded funds (ETFs), however, aren’t protected under current laws. Under the new law, ETF research reports won't be considered offers under securities law, even if the brokers or dealers take part in the registered offering of the investment fund’s securities.

In our ETFG Quant Movers, we saw a shift out of domestic health care centered ETFs and gains in global volatility tracking funds. As expected, winners included PowerShares FTSE RAFI Developed Markets ex-US Small-Mid Portfolio, iShares Edge MSCI Min Vol Europe ETF, and Legg Mason Low Volatility High Dividend ETF, which all gained close to 20% this week alone. We saw similar effects in the opposite direction with CSOP FTSE China A50 ETF and Vanguard Health Care ETF which slid 20.46% and 18.19% respectively. Concerns are also warranted for AGA, BOM, and BLNG, which have popped up on ETF Global Liquidation Watch List – October 2017 with an AUM of under $1 million.

Thank you for reading the ETF Global Perspectives!

ETFG 21 Day Free Trial:  https://www.etfg.com/signup/quick

_____________________________________________________________
Assumptions, opinions and estimates constitute our judgment as of the date of this material and are subject to change without notice.  ETF Global LLC (“ETFG”) and its affiliates and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively ETFG Parties) do not guarantee the accuracy, completeness, adequacy or timeliness of any information, including ratings and rankings and are not responsible for errors and omissions or for the results obtained from the use of such information and ETFG Parties shall have no liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of such information. ETFG PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE.  In no event shall ETFG Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of the information contained in this document even if advised of the possibility of such damages.

ETFG ratings and rankings are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities or to make any investment decisions. ETFG ratings and rankings should not be relied on when making any investment or other business decision.  ETFG’s opinions and analyses do not address the suitability of any security.  ETFG does not act as a fiduciary or an investment advisor.  While ETFG has obtained information from sources they believe to be reliable, ETFG does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities, financial instruments or strategies mentioned herein may not be suitable for all investors.  Any opinions expressed herein are given in good faith, are subject to change without notice, and are only correct as of the stated date of their issue.  Prices, values, or income from any securities or investments mentioned in this report may fall against the interests of the investor and the investor may get back less than the amount invested.  Where an investment is described as being likely to yield income, please note that the amount of income that the investor will receive from such an investment may fluctuate.  Where an investment or security is denominated in a different currency to the investor's currency of reference, changes in rates of exchange may have an adverse effect on the value, price or income of or from that investment to the investor.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.